Mitchell F. Weiss, MD

Coming to Monmouth in 2003 after completing his residency at Memorial Sloan- Kettering, Mitchell Weiss, M.D., earned his doctor of medicine degree from Pritzker School of Medicine at the University of Chicago Medical School. His expertise is in IMRT and his research has been published by the American Society of Clinical Oncology and in the International Journal of Radiation Oncology, Biology, Physics and Obstetrics & Gynecology. Most recently, Dr. Weiss — who has a special interest in the treatment of head and neck cancers — announced that Monmouth has joined a select group of major academic institutions in a clinical trial that delves into reducing two serious complications experienced by head and neck cancer patients during radiation treatment. Monmouth’s Institute for Advanced Radiation Oncology is a research site for the national study, which will explore whether use of amifostine in conjunction with IMRT can decrease mouth sores and ulcerations and dry mouth — devastating symptoms of radiation therapy for the vast majority of head and neck cancer patients — while maximizing a head and neck cancer patient’s chance for a cure. The trial also is being conducted at only a handful of leading academic facilities in the United States, including The University of Texas M. D. Anderson Cancer Center in Houston, H. Lee Moffitt Cancer Center & Research Institute at the University of South Florida in Tampa, Washington University School of Medicine in St Louis, University of Nebraska at Omaha and San-Diego-based Radiation Medical Group.